CUV 0.67% $14.72 clinuvel pharmaceuticals limited

"It is estimated there are 5,000 to 10,000 EPP patients...

  1. 706 Posts.
    lightbulb Created with Sketch. 173
    "It is estimated there are 5,000 to 10,000 EPP patients worldwide"

    At ~$130K per patient that would be a $650M-$1.3B opportunity, per annum.

    But just keep popping in every few hours to tell us that it's only 3,000 - perhaps it will make you feel less bitter with other people's success?
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.